Daniel Kazado insider trades: Immune Pharmaceuticals (IMNP) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Daniel reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 4, 2017 | IMNP | ↑ Buy | 76,503 | $0.19 | $14K | Direct | Jan 4, 2017 (0d) |
| Dec 16, 2016 | IMNP | ↑ Buy | 161,377 | $0.19 | $30K | Direct | Dec 20, 2016 (4d) |
| Aug 4, 2016 | IMNP | ↑ Buy | 666,667 | $0.45 | $300K | Direct | Aug 4, 2016 (0d) |
| Dec 7, 2015 | IMNP | ↑ Buy | 150,000 | $0.78 | $117K | Direct | Dec 8, 2015 (1d) |
| Sep 14, 2015 | IMNP | ↑ Buy | 50,000 | $1.47 | $73K | Direct | Sep 16, 2015 (2d) |
| Nov 26, 2014 | IMNP | ↑ Buy | 8,000 | $2.50 | $20K | Direct | Dec 3, 2014 (7d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Daniel Kazado's insider trades
Daniel Kazado is a director at Immune Pharmaceuticals (IMNP). Since Nov 26, 2014, Daniel has reported 6 open-market purchases worth $555K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (5 filings), other transactions (3 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IMNP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.